Concentration of an Integral Membrane Protein, CD43

Total Page:16

File Type:pdf, Size:1020Kb

Concentration of an Integral Membrane Protein, CD43 Concentration of an Integral Membrane Protein, CD43 (Leukosialin, Sialophofin), in the Cleavage Furrow through the Interaction of Its Cytoplasmic Domain with Actin-based Cytoskeletons Shigenobu Yonemura,* Akira Nagafuchi,* Naruki Sato,** and Shoichiro Tsukita*r * Laboratory of Cell Biology, Department of Information Physiology,National Institute for Physiological Sciences, Okazaki, Aichi 444, Japan; and *Department of Physiological Sciences, School of Life Science, The Graduate University of Advanced Studies, Myodaiji-cho, Okazaki, Aichi 444, Japan Abstract. In leukocytes such as thymocytes and consisting of the extracellular domain of mouse Downloaded from http://rupress.org/jcb/article-pdf/120/2/437/1256004/437.pdf by guest on 24 September 2021 basophilic leukemia cells, a glycosilated integral mem- E-cadherin and the transmembrane/cytoplasmic do- brane protein called CIM3 (leukosialin or sialopho- main of rat CD43, and introduced it into mouse L rin), which is defective in patients with Wiskott- fibroblasts lacking both endogenous CD43 and Aldrich syndrome, was highly concentrated in the E-cadherin. In dividing transfectants, the chimeric cleavage furrow during cytokinesis. Not only at the molecules were concentrated in the cleavage furrow mitotic phase but also at interphase, CIM3 was pre- together with ERM, and both proteins were precisely cisely colocalized with ezrin-radixin-moesin family colocalized throughout the cell cycle. Furthermore, members (ERM), which were previously reported to using this transfection system, we narrowed down the play an important role in the plasma membrane-actin domain responsible for the CD43-concentration in the filament association in general. At the electron micro- cleavage furrow. Based on these findings, we conclude scopic level, throughout the cell cycle, both CIM3 and that CD43 is concentrated in the cleavage furrow ERM were tightly associated with microvilli, provid- through the direct or indirect interaction of its cyto- ing membrane attachment sites for actin filaments. We plasmic domain with ERM and actin filaments. constructed a cDNA encoding a chimeric molecule HE mechanism of cytokinesis has attracted increasing furrow is limited at the molecular level. This information is interest among cell biologists (for review see Mabuchi, indispensable in understanding the molecular basis for the T 1986; Rappaport, 1986; Satterwhite and Pollard, formation of cleavage furrows. 1992). Before cytokinesis, an unknown signal is thought to To clarify the molecular linkage from the actin filaments be transferred from the mitotic apparatus to the equatorial to the plasma membrane in the cleavage furrow, the first cortex, inducing the formation of a bundle of aligned actin protein that should be identified is an actin-modulating pro- filaments called the contractile ring just beneath the plasma tein. Many actin-modulating proteins reportedly show high membrane (Perry et al., 1971; Schroeder, 1973). At cytoki- affinity for the plasma membranes; for example, gelsolin nesis, the constriction of this ring results in the formation of (Janmey et al., 1987; Hartwig et al., 1989), lipocortin-85 the cleavage furrow and finally in the cell division. The me- (lkebuchi and Waisman, 1990), myosin-I (Adams and Pol- chanical force for the constriction is generated through the lard, 1989; Miyata et al., 1989; Mooseker et al., 1989), interaction between actin filaments and myosin-II inside the actin-binding protein (Fox, 1985; Ohta et al., 1991), spectrin ring (Fujiwara and Pollard, 1976; Mabuchi and Okuno, (for review see Bennet, 1989), the myristoylated, alanine- 1977; Yumura and Fukui, 1985; DeLozanne and Spudich, rich C kinase substrate (Hartwig et al., 1992), and ponticu- 1987; Knecht and Loomis, 1987; Karess et al., 1991). So far, lin (Shariff and Luna, 1990). However, none of them are various types of proteins, including actin and myosin-H, are reportedly concentrated in the cleavage furrow during cyto- reportedly concentrated in the cleavage furrow (Sanger et kinesis. Recently, an 82-kD protein called radixin, a barbed al., 1987, 1989; Ishidate and Mabuchi, 1988; Schweisguth end-capping, actin-modulating protein, has been reported to et al., 1990; Earnshaw and Cooke, 1991; Yonemura et al., be highly concentrated in the cleavage furrow in various 1991). However, despite these intensive studies, knowledge types of cells (Tsukita et al., 1989; Sato et al., 1991). Se- of the molecular architecture of the contractile ring remains quence analysis of radixin eDNA has revealed that radixin fragmentary. Especially, information on the way actin fila- is highly homologous to ezrin and moesin (Gould et al., ments associate with the plasma membrane in the cleavage 1989; Turunen et al., 1989; Funayama et al., 1991; Lankes The Rockefeller University Press, 0021-9525/93/01/437/13 $2.00 The Journal of Cell Biology, Volume 120, Number 2, January 1993 437-449 437 and Furthmayr, 1991), and that there is a gene family consist- ERM. The results of this study will lead us to a better under- ing of ezrin, radixin, and moesin, which we call the ERM ~ standing of the molecular mechanism of the cleavage furrow family (Sato et al., 1992; Tsukita et al., 1992). Recent close formation. immunofluorescence microscopic analyses have shown that the ERM family plays a crucial role in the association of ac- tin filaments with the plasma membrane in general. Con- Materials and Methods sidering that our anti-radixin pAb and mAb more or less crossreacted with ezrin and moesin, we should strictly say Cells and Antibodies that ERM family members are concentrated at the cleavage Thymocytes from 2-wk-old Wistar rats were collected by centrifugation, furrow (see details in Sato et al., 1992). Interestingly, the resuspended in RPMI-1640 supplemented with 10% FCS, and incubated for 30-60 rain at 37~ RBL-2H3 cells were obtained from the Japanese Can- NH2-terminal half of ERM significantly resembles that of cer Research Resources Bank (Tokyo, Japan) and cultured in RPMI-1640 band 4.1 protein, a major undercoat constituent of the eryth- with 10% FCS. Mouse fibroblastic L cells (Earle, 1943) and their E-cad- rocyte membrane (Sato et al., 1992). In erythrocyte mem- herin transfectants, EL8 cells (Nagafuchi et al., 1987), were cultured in branes, band 4.1 protein binds to an integral membrane pro- DME with 10% FCS. tein called glycophorin C through its NHe-terminal domain The following antibodies were used: anti-rat CD43 mAb, W3/13 (Cedar- lane Laboratories Limited, Hornby, Ontario, Canada); anti-radixin pAb, (Leto et al., 1986). Therefore, it is tempting to speculate that pAb-I1 (Tsukita et al., 1989); anti-radixin mAb, CR22 (Sato et al., 1991); in the cleavage furrow, ERM directly binds actin filaments anti-E-cadherin pAb (Nagafuchi et al., 1987); and anti-E-cadherin mAb, to a membrane protein (glycophorin-like?) at its NH2- ECCD-2 (Shirayoshi et al., 1986). Since pAb-I1 and mAb-CR22 were re- terminal domain. cently found to more or less crossreact with ezrin and moesin (Sato et al., 1992), we tentatively call these antibodies anti-ERM pAb and mAb, respec- Downloaded from http://rupress.org/jcb/article-pdf/120/2/437/1256004/437.pdf by guest on 24 September 2021 Since actin filaments are recruited preferentially into the tively. Rhodamine-phaUoidin (Molecular Probes, Inc., Eugene, OR) was cleavage furrow by migration of preexisting filaments in the used to stain aetin filaments. Chromosomes were visualized with 4'6- cell cortex and are not all assembled de novo in the furrow diamidino-2-phe~'Iindole dihydrochloride. (Cao and Wang, 1990a), the membrane protein such as the above putative ERM-anchoring protein, which is responsi- Immunofluorescence Microscopy ble for linking actin filaments to the plasma membrane, is All procedures were carried out at room temperature. Cells were fixed with likely to accumulate in the cleavage furrow. However, the oc- 4% fresh formaldehyde in 0.1 M Hepes buffer (pH 7.5) for 15 min. After currence of such a cleavage furrow-accumulated membrane washing three times with PBS containing 30 mM glycine (glycine-PBS), protein has not often been discussed in the field of cytokine- cells were soaked in blocking solution ~lycine-PBS containing 2 % normal goat serum) for 5 rain and incubated with W3/13 or anti-E-cadherin pAb sis. We recently noticed .that de Petris (1984), during the diluted with the blocking solution for 30 min. They were then washed with course of his studies on capping of the cell surface glycopro- glycine-PBS three times, treated with 0.2 % Triton X-100 in glycine-PBS for teins in lymphoid cells, described the concentration of 15 rain, and washed with glycine-PBS three times. After being soaked in W3/13 antigen in the cleavage furrow in dividing rat thymo- the blocking solution for 5 min, cells were incubated with anti-ERM pAh cytes. The W3/13 antigen is a rat homologue of human CIM3 or mAb diluted with the blocking solution for 1 h, washed three times, and soaked in the blocking solution for 5 min. They were then incubated with (leukosialin or sialophorin) (Killeen et al., 1987), which is secondary antibodies diluted with the blocking solution for 30 min. FITC- an integral membrane protein expressed in most leukocytes conjugated sheep anti-mouse Ig antibody and rhodamine-conjugated don- and platelets, and is defective in patients with the X-chromo- key anti-rabbit Ig (Amersham International plc, Amersham, UK) were used some-linked immunodeficiency disorder, Wiskott-Aldrich as secondary antibodies. For some studies, rhodamine-phalloidin and/or 4'6-diamidino-2-phenylindole dihydrochloride were mixed with the second- syndrome (for review see Remold-O'Donnell and Rosen, ary antibody. Cells were washed three times and then mounted in 90% 1990). Considering that CD43 is heavily sialoglycosylated glycerol-PBS containing 0.1% para-phenylendiamine. Some samples were just like glycophorin C (Brown et al., 1981) and that one anti- not treated with detergent or with anti-ERM antibody.
Recommended publications
  • Platelet Membrane Glycoproteins: a Historical Review*
    577 Platelet Membrane Glycoproteins: A Historical Review* Alan T. Nurden, PhD1 1 L’Institut de Rhythmologie et Modélisation Cardiaque (LIRYC), Address for correspondence Alan T. Nurden, PhD, L’Institut de Plateforme Technologique et d’Innovation Biomédicale (PTIB), Rhythmologie et Modélisation Cardiaque, Plateforme Technologique Hôpital Xavier Arnozan, Pessac, France et d’Innovation Biomédicale, Hôpital Xavier Arnozan, Avenue du Haut- Lévèque, 33600 Pessac, France (e-mail: [email protected]). Semin Thromb Hemost 2014;40:577–584. Abstract The search for the components of the platelet surface that mediate platelet adhesion and platelet aggregation began for earnest in the late 1960s when electron microscopy demonstrated the presence of a carbohydrate-rich, negatively charged outer coat that was called the “glycocalyx.” Progressively, electrophoretic procedures were developed that identified the major membrane glycoproteins (GP) that constitute this layer. Studies on inherited disorders of platelets then permitted the designation of the major effectors of platelet function. This began with the discovery in Paris that platelets of patients with Glanzmann thrombasthenia, an inherited disorder of platelet aggregation, Keywords lacked two major GP. Subsequent studies established the role for the GPIIb-IIIa complex ► platelet (now known as integrin αIIbβ3)inbindingfibrinogen and other adhesive proteins on ► inherited disorder activated platelets and the formation of the protein bridges that join platelets together ► membrane in the platelet aggregate. This was quickly followed by the observation that platelets of glycoproteins patients with the Bernard–Soulier syndrome, with macrothrombocytopenia and a ► Glanzmann distinct disorder of platelet adhesion, lacked the carbohydrate-rich, negatively charged, thrombasthenia GPIb. It was shown that GPIb, through its interaction with von Willebrand factor, ► Bernard–Soulier mediated platelet attachment to injured sites in the vessel wall.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Surface Glycoproteomic Analysis of Hepatocellular Carcinoma Cells by Affinity Enrichment and Mass Spectrometric Identification
    Glycoconj J (2012) 29:411–424 DOI 10.1007/s10719-012-9420-3 Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification Wei Mi & Wei Jia & Zhaobin Zheng & Jinglan Wang & Yun Cai & Wantao Ying & Xiaohong Qian Received: 14 April 2012 /Revised: 5 June 2012 /Accepted: 12 June 2012 /Published online: 1 July 2012 # Springer Science+Business Media, LLC 2012 Abstract Cell surface glycoproteins are one of the most surface-capturing (CSC) technique was an approach specif- frequently observed phenomena correlated with malignant ically targeted at membrane glycoproteins involving the growth. Hepatocellular carcinoma (HCC) is one of the most affinity capture of membrane glycoproteins using glycan malignant tumors in the world. The majority of hepatocel- biotinylation labeling on intact cell surfaces. To characterize lular carcinoma cell surface proteins are modified by glyco- the cell surface glycoproteome and probe the mechanism of sylation in the process of tumor invasion and metastasis. tumor invasion and metastasis of HCC, we have modified Therefore, characterization of cell surface glycoproteins can and evaluated the cell surface-capturing strategy, and ap- provide important information for diagnosis and treatment plied it for surface glycoproteomic analysis of hepatocellu- of liver cancer, and also represent a promising source of lar carcinoma cells. In total, 119 glycosylation sites on 116 potential diagnostic biomarkers and therapeutic targets for unique glycopeptides were identified, corresponding to 79 hepatocellular carcinoma. However, cell surface glycopro- different protein species. Of these, 65 (54.6 %) new pre- teins of HCC have been seldom identified by proteomics dicted glycosylation sites were identified that had not pre- approaches because of their hydrophobic nature, poor solu- viously been determined experimentally.
    [Show full text]
  • ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease
    International Journal of Molecular Sciences Review ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease Francesca Tosetti 1,* , Massimo Alessio 2, Alessandro Poggi 1,† and Maria Raffaella Zocchi 3,† 1 Molecular Oncology and Angiogenesis Unit, IRCCS Ospedale Policlinico S. Martino Largo R. Benzi 10, 16132 Genoa, Italy; [email protected] 2 Proteome Biochemistry, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; [email protected] 3 Division of Immunology, Transplants and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work as last author. Abstract: Enzymes, once considered static molecular machines acting in defined spatial patterns and sites of action, move to different intra- and extracellular locations, changing their function. This topological regulation revealed a close cross-talk between proteases and signaling events involving post-translational modifications, membrane tyrosine kinase receptors and G-protein coupled recep- tors, motor proteins shuttling cargos in intracellular vesicles, and small-molecule messengers. Here, we highlight recent advances in our knowledge of regulation and function of A Disintegrin And Metalloproteinase (ADAM) endopeptidases at specific subcellular sites, or in multimolecular com- plexes, with a special focus on ADAM10, and tumor necrosis factor-α convertase (TACE/ADAM17), since these two enzymes belong to the same family, share selected substrates and bioactivity. We will discuss some examples of ADAM10 activity modulated by changing partners and subcellular compartmentalization, with the underlying hypothesis that restraining protease activity by spatial Citation: Tosetti, F.; Alessio, M.; segregation is a complex and powerful regulatory tool.
    [Show full text]
  • IHC) Outreach Services
    IIImmunohistochemistry (IHC) Outreach Services Note type of fixative used if not neutral buffered formalin. Note type of tissue/specimen Unless specified otherwise, positive and negative controls react satisfactorily. Available Chromogen – All markers have been validated with 3,3’-Diaminobenzidine Tetrahydrochloride (DAB) which results in a brown/black precipitate. DAB is the routine chromogen. In addition, some markers have also been validated using the Fast Red (RED), which results in a red precipitate. If available with both chromogens and one is not selected, the def ault will be the DAB chromogen. Antibody Common Applications St aining Charac teristi cs Actin (muscl e sp eci fic ) Smoo th, ske letal & ca rdiac musc le Cytoplasm ic Actin (smoo th muscle ) Smoo th muscl e an d myoep itheli al cel ls Cytoplasm ic and memb rane ALK Pr otein ALK1 posi tive lymp homa s Cytoplasm ic and/or nuclea r Alph a-1-Antitr ypsi n Demo nstr ates A-1-AT in liver Cytoplasm ic (A-1-AT) Bcl-2 Oncop rotein Foll icula r lymph oma an d so ft tiss ue Cytoplasm ic tumors Bcl-6 Foll icula r lymph oma Nucl ear Ber-EP 4, Epithelia l Antige n Aden oca rcin oma vs. meso the liom a Memb rane and cytoplasm ic. The and epithelial tumors membrane staining is preferentially basolateral. Beta-Amyloid Pos t mo rt em dia gnos is of demen tia E xtr acel lular de pos ition (am yloid plaques), vascular deposition (amyloid angiopathy) BRS T-3, (B72.3) Aden oca rcin oma vs.
    [Show full text]
  • CD Markers Are Routinely Used for the Immunophenotyping of Cells
    ptglab.com 1 CD MARKER ANTIBODIES www.ptglab.com Introduction The cluster of differentiation (abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules. So-called CD markers are routinely used for the immunophenotyping of cells. Despite this use, they are not limited to roles in the immune system and perform a variety of roles in cell differentiation, adhesion, migration, blood clotting, gamete fertilization, amino acid transport and apoptosis, among many others. As such, Proteintech’s mini catalog featuring its antibodies targeting CD markers is applicable to a wide range of research disciplines. PRODUCT FOCUS PECAM1 Platelet endothelial cell adhesion of blood vessels – making up a large portion molecule-1 (PECAM1), also known as cluster of its intracellular junctions. PECAM-1 is also CD Number of differentiation 31 (CD31), is a member of present on the surface of hematopoietic the immunoglobulin gene superfamily of cell cells and immune cells including platelets, CD31 adhesion molecules. It is highly expressed monocytes, neutrophils, natural killer cells, on the surface of the endothelium – the thin megakaryocytes and some types of T-cell. Catalog Number layer of endothelial cells lining the interior 11256-1-AP Type Rabbit Polyclonal Applications ELISA, FC, IF, IHC, IP, WB 16 Publications Immunohistochemical of paraffin-embedded Figure 1: Immunofluorescence staining human hepatocirrhosis using PECAM1, CD31 of PECAM1 (11256-1-AP), Alexa 488 goat antibody (11265-1-AP) at a dilution of 1:50 anti-rabbit (green), and smooth muscle KD/KO Validated (40x objective). alpha-actin (red), courtesy of Nicola Smart. PECAM1: Customer Testimonial Nicola Smart, a cardiovascular researcher “As you can see [the immunostaining] is and a group leader at the University of extremely clean and specific [and] displays Oxford, has said of the PECAM1 antibody strong intercellular junction expression, (11265-1-AP) that it “worked beautifully as expected for a cell adhesion molecule.” on every occasion I’ve tried it.” Proteintech thanks Dr.
    [Show full text]
  • Platelet Surface Glycoproteins. Studies on Resting and Activated Platelets and Platelet Membrane Microparticles in Normal Subjec
    Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J N George, … , N Kieffer, P J Newman J Clin Invest. 1986;78(2):340-348. https://doi.org/10.1172/JCI112582. Research Article The accurate definition of surface glycoprotein abnormalities in circulating platelets may provide better understanding of bleeding and thrombotic disorders. Platelet surface glycoproteins were measured on intact platelets in whole blood and platelet membrane microparticles were assayed in cell-free plasma using 125I-monoclonal antibodies. The glycoproteins (GP) studied were: GP Ib and GP IIb-IIIa, two of the major intrinsic plasma membrane glycoproteins; GMP-140, an alpha- granule membrane glycoprotein that becomes exposed on the platelet surface following secretion; and thrombospondin (TSP), an alpha-granule secreted glycoprotein that rebinds to the platelet surface. Thrombin-induced secretion in normal platelets caused the appearance of GMP-140 and TSP on the platelet surface, increased exposure of GP IIb-IIIa, and decreased antibody binding to GP Ib. Patients with adult respiratory distress syndrome had an increased concentration of GMP-140 and TSP on the surface of their platelets, demonstrating in vivo platelet secretion, but had no increase of platelet microparticles in their plasma. In contrast, patients after cardiac surgery with cardiopulmonary bypass demonstrated changes consistent with membrane fragmentation without secretion: a decreased platelet surface concentration of GP Ib and GP IIb with no increase of GMP-140 and TSP, and an increased plasma concentration of platelet membrane microparticles. These methods will help to define acquired abnormalities of platelet surface glycoproteins.
    [Show full text]
  • Induces Antigen Presentation in B Cells Cell-Activating Factor of The
    B Cell Maturation Antigen, the Receptor for a Proliferation-Inducing Ligand and B Cell-Activating Factor of the TNF Family, Induces Antigen Presentation in B Cells This information is current as of September 27, 2021. Min Yang, Hidenori Hase, Diana Legarda-Addison, Leena Varughese, Brian Seed and Adrian T. Ting J Immunol 2005; 175:2814-2824; ; doi: 10.4049/jimmunol.175.5.2814 http://www.jimmunol.org/content/175/5/2814 Downloaded from References This article cites 54 articles, 36 of which you can access for free at: http://www.jimmunol.org/content/175/5/2814.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology B Cell Maturation Antigen, the Receptor for a Proliferation-Inducing Ligand and B Cell-Activating Factor of the TNF Family, Induces Antigen Presentation in B Cells1 Min Yang,* Hidenori Hase,* Diana Legarda-Addison,* Leena Varughese,* Brian Seed,† and Adrian T.
    [Show full text]
  • CD43 Expression in Malignant Melanoma: a Diagnostic Pitfall
    Asian Archives of Pathology 2014; Vol. 10 No.4, 97-109 Case Report CD43 Expression in Malignant Melanoma: A Diagnostic Pitfall Sanya Sukpanichnant Received: 24 September 2014; accepted 30 October 2014. ABSTRACT CD43 is commonly concerned as a marker for hematopoietic cells and, at times, a preferential T-cell marker. However, a number of non-hematologic cancers, mostly carcinoma, can express CD43. Recently, a case of malignant melanoma mimicking malignant lymphoma by cytomorphology was reported to express CD43 as well as melanoma markers but the other hematologic markers [Buehler et al. Diagn Cytopathol 2012;40:619- 23]. This is another case report. A 52-year-old man suffered from a rapidly growing left tonsillar mass for one month causing slurred speech. An incisional biopsy showed gray tissue and, beneath the epithelium, a sheet of - lastic lymphoma, as the original workup showed focal and faint CD138 expression but negative keratins and CD45. On consultation, hematologic malignancy and malignant melanoma were considered. The tumor cells express CD43, CD68 (focal), S-100, HMB45, Melan A, and vimentin. The negative markers included CD3, CD20, CD30, CD79a, MUM1, PAX5, kappa, lambda, and CK5/6. The proliferation index was high (70-75%) another case report of malignant melanoma with CD43 expression, mimicking malignant lymphoma, raises the awareness of diagnostic pitfall when dealing with undifferentiated tumors showing only CD43 expression among various hematologic markers. A panel for keratins, vimentin, S-100, CD45, CD30, and CD138 will be helpful when dealing with undifferentiated large cell tumor. Keywords: melanoma *This case report has been presented partly in a poster session in the 12th Japanese-Korean Lymphoreticular- Workshop 2014 in conjunction with the 5th Asian Hematopathology Symposium on January 25, 2014 at Nagoya University Hospital Lecture Hall.
    [Show full text]
  • Altered O-Glycan Synthesis in Lymphocytes from Patients with Wiskott-Aldrich Syndrome by Friedrich Piller,* Frangoise Le Deist, Kenneth 1
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Altered O-Glycan Synthesis in Lymphocytes from Patients with Wiskott-Aldrich Syndrome By Friedrich Piller,* Frangoise Le Deist, Kenneth 1 . Weinberg,§ Robertson Parkman,S and Minoru Fukuda* From the *La Jolla Cancer Research Foundation, La Jolla, California 92037, the #INSERM U132, Hopital Necker/Enfants Malades, F7S01S Paris, France; and the §Division of Research Immunology/Bone Marrow Transplantation, Childrens Hospital, Los Angeles, California 90033 Summary The only molecular defect reported for the X-linked immunodeficiency WiskottAldrich syndrome (WAS) is the abnormal electrophoretic behavior of the major T lymphocyte sialoglycoprotein CD43. Since the 70 to 80 O-linked carbohydrate chains of CD43 are known to influence markedly its electrophoretic mobility, we analyzed the structure and the biosynthesis of O-glycans of CD43 in lymphocytes from patients with WAS. Immunofluorescence analysis with the carbohydrate dependent anti-CD43 antibody T305 revealed that in 10 out ofthe 12 WAS patients tested increased numbers ofT lymphocytes carry on CD43 an epitope which on normal lymphocytes is expressed only after activation. Other activation antigens were absent from WAS lymphocytes . Western blots of WAS cell lysates displayed a high molecular mass form of CD43 which reacted with the T305 antibody and which could be found on in vivo activated lymphocytes but was absent from normal unstimulated lymphocytes. To examine the O-glycan structures, carbohydrate labeled CD43 was immunoprecipitated and the released oligosaccharides identified. WAS lymphocyte CD43 was found to carry predominantly the branched structure NeuNAca2-3Gala1--"3 (NeuNAca2-3Ga101-4G1cNAc01-6) Ga1NAcOH whereas normal lymphocytes carry the structure NeuNAca2-3Ga101--"3 (NeuNAca2--"6) Ga1NAcOH.
    [Show full text]
  • SUPPLEMENTARY APPENDIX Improved Classification of Leukemic B-Cell Lymphoproliferative Disorders Using a Transcriptional and Genetic Classifier
    SUPPLEMENTARY APPENDIX Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier Alba Navarro, 1,2* Guillem Clot, 1,2* Alejandra Martínez-Trillos, 1,2 Magda Pinyol, 2,3 Pedro Jares, 1,2 Blanca González-Farré, 1,2 Daniel Martínez, 1,2 Nicola Trim, 4 Verónica Fernández, 1 Neus Villamor, 1,2 Dolors Colomer, 1,2 Dolors Costa, 1,2 Itziar Salaverria, 1,2 , David Martín- Garcia, 1,2 Wendy Erber, 5 Cristina López, 6,7 Sandrine Jayne, 8 Reiner Siebert, 6,7 Martin J. S. Dyer, 8 Adrian Wiestner, 9 Wyndham H. Wilson, 10 Marta Aymerich, 1,2 Armando López-Guillermo, 1,2 Àlex Sánchez, 11,12 Elías Campo, 1,2 Estella Matutes 2 and Sílvia Beà 1,2 *AN and GC contributed equally to this work 1Institut d’Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Universitat de Barcelona, Spain; 2Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain; 3Genomics Unit, IDIBAPS, Barcelona, Spain; 4West Midlands Regional Genetics Laboratory, Birmingham, UK; 5School of Pathology and Laboratory Medicine, The University of Western Australia, Crawley, WA, Australia; 6Institute of Human Genetics, University Kiel, Germany; 7In - stitute of Human Genetics, University Hospital of Ulm, Germany; 8Ernest and Helen Scott Haematological Research Institute, Department of Biochemistry, Uni - versity of Leicester, UK; 9National Heart, Lung, and Blood Institute, Bethesda, MD, USA; 10 Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; 11 Department of Genetics Microbiology and Statistics, University of Barcelona, Spain and 12 Statistic and Bioin - formatics Unit, Vall d’Hebron Research Institute, Barcelona, Spain Correspondence: [email protected] doi:10.3324/haematol.2016.160374 SUPPLEMENTARY INFORMATION Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier Navarro A & Clot G, et al.
    [Show full text]
  • PMP22 Earrying the Trembler Or Tremblerj Mutation Is Intracellularly Retained in Myelinating Schwann Cells in Vivo
    PMP22 earrying the Trembler or TremblerJ mutation is intracellularly retained in myelinating Schwann cells in vivo by: Joshua Joseph Colby Center for Neuronal Survival Montreal Neurological Institute De partment of Pathology McGill University Montreai, Quebec, Canada Submitted in March, 2000 A thesis submitted to the Faculty of Graduate Studies and Research in partial Mfillment of the requirements for the degree of Master of Science (Pathology) O Joshua Colby, 2000 National Library Biiiothbque nationale du Canada Acquisitions arid Acquisitions et Bibliraphic Services services bibliographiques 395 W.lingtori Street 395. rwWeYingiMi OtIawaON KlAW OWawaON KlAONQ canada Canada The author has granteci a non- L'auteur a accordé une licence non exclusive licence aUowing the exclusive permettant à la National Lhrary of Canada to Bibliothèque nationaie du Canada de reproduce, 10- distri'bute or seii reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfiche/nIm, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'autwr conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fiom it Ni la îhèse ni des extraits substantiels may be printed or othecwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits saus son permission. autorisation. The most common cause of human hereditary neuropathies is a duplication in the peripheral myelin protein-22 (PMP22) gene. PM.22 is an integral membrane glycoprotein expressed primdy in the compact myelin of the mammalian peripheral nervous system.
    [Show full text]